Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Passy Muir is a specialized medical device company that focuses on communication and swallowing solutions for patients with tracheostomies and ventilator dependence. The company's primary product is the Passy Muir Valve (PMV), which is the only closed-position "no-leak" speaking valve designed to restore speech and improve swallowing. By redirecting airflow through the upper airway, the PMV helps restore subglottic pressure, which facilitates weaning from mechanical ventilation and reduces aspiration risk. Passy Muir is recognized globally for its commitment to clinical education, providing extensive resources and training for speech-language pathologists and respiratory therapists. Their products are used across the continuum of care, including acute care hospitals, long-term acute care facilities, and home health settings. Founded by a patient for patients, the company maintains a strong focus on improving the quality of life and clinical outcomes for individuals with complex airway needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Passy Muir.